Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the study page remains inaccessible with a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:29:55.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH transition notice about using “Super Intelligence” in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T15:25:49.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T15:09:51.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T15:15:40.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating the record is currently inaccessible. The visible layout shows the standard site chrome and an error message, replacing the prior study details and related information.
    Difference
    19%
    Check dated 2026-09-21T20:52:02.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.5 to v3.6.6, reflecting a new version of the clinical trial record. It indicates an internal update to the page rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-08-31T17:24:28.000Z thumbnail image

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.